
Biotechnology and Pharmaceutical Services Outsourcing Market Share, Size, Trends, Industry Analysis Report, By Service (Product Design & Development, Consulting, Regulatory Affairs, Product Maintenance, Auditing & Assessment, Product Testing & Validation,
Description
Biotechnology and Pharmaceutical Services Outsourcing Market Share, Size, Trends, Industry Analysis Report, By Service (Product Design & Development, Consulting, Regulatory Affairs, Product Maintenance, Auditing & Assessment, Product Testing & Validation, Others); By End-User; By Region; Segment Forecast, 2024- 2032
The global biotechnology and pharmaceutical services outsourcing market size is expected to reach USD 111.86 billion by 2032, according to a new study by Polaris Market Research. The report “Biotechnology and Pharmaceutical Services Outsourcing Market Share, Size, Trends, Industry Analysis Report, By Service (Product Design & Development, Consulting, Regulatory Affairs, Product Maintenance, Auditing & Assessment, Product Testing & Validation, Others); By End-User; By Region; Segment Forecast, 2024- 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The utilization of outsourcing for biotechnology and pharmaceutical services has demonstrated its efficacy in curtailing infrastructural and operational expenses. Nonetheless, the industry has witnessed a notable decline in its new product portfolio due to a reduction in research and development endeavors. Consequently, numerous companies have resorted to internal downsizing and increased outsourcing to trim capital and payroll costs.
Outsourcing has transformed into a prevailing industry trend, encompassing a comprehensive range of corporate activities, spanning from screening and lead identification to toxicology, clinical trials, and various other procedures in preclinical investigations.
Biotechnology and pharmaceutical services outsourcing finds application in auditing and evaluation, consulting, product maintenance, regulatory affairs, and testing and validation within the drug discovery sector. Pharmaceutical firms, in particular, heavily rely on these services to maintain competitiveness in the market.
Regenerative medicine, impactful in healthcare, emerges as a prominent area for biotech and pharmaceutical services outsourcing. These experimental treatments aim to restore function by replacing or regenerating organs, cells, or tissues following injury or disease. Although this economic-driven expansion has led to reduced industry efficiency, the trend of outsourcing in biotech and pharmaceuticals persists. Despite potential shortcomings in promoting innovation, the sector anticipates continued growth in outsourcing practices.
Moreover, the biotechnology and pharmaceutical services outsourcing market is poised for growth due to escalating regulatory frameworks and heightened risks associated with biotechnology drug patents. The increasing presence of full-service providers is expected to meet the rising demand for accessible drug development and manufacturing, further expanding the market. Anticipated drivers include new product launches, heightened infrastructure investments, and innovative medication delivery methods. The healthcare industry's fierce competition is prompting numerous companies to opt for outsourcing as a strategic choice.
Biotechnology and Pharmaceutical Services Outsourcing Market Report Highlights
In 2023, the product design & development segment is expected to witness the highest growth during the forecast period owing to advanced technologies and streamlined processes.
The Pharma segment is expected to dominate the biotechnology and pharmaceutical services outsourcing market during the forecast period. The factor is attributed to increased R&D expenditure.
In 2023, North America accounted for the largest revenue share due to the presence of major players, technological advancements, and increased R&D spending.
The market is highly competitive owing to the existence of market players with a global presence, including Charles River Laboratories International, Inc., ICON plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (LabCorp), and Lonza Group, among others.
Polaris Market Research has segmented the biotechnology and pharmaceutical services outsourcing market report based on service, end-user, and region:
Biotechnology and Pharmaceutical Services Outsourcing, Service Outlook (Revenue - USD Billion, 2019 - 2032)
Product Design & Development
Consulting
Regulatory Affairs
Product Maintenance
Auditing & Assessment
Product Testing & Validation
Others
Biotechnology and Pharmaceutical Services Outsourcing, End-User Outlook (Revenue - USD Billion, 2019 - 2032)
Biotech
Pharma
Biotechnology and Pharmaceutical Services Outsourcing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Rest of Europe
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
119 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Biotechnology and Pharmaceutical Services Outsourcing Market Insights
- 4.1. Biotechnology and Pharmaceutical Services Outsourcing Market – Industry Snapshot
- 4.2. Biotechnology and Pharmaceutical Services Outsourcing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Economic advantages linked to the process of drug discovery are spurring the product demand
- 4.2.1.2. Increased demand and competition are driving biotechnology and pharmaceutical services outsourcing market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory challenges are likely to impede the market biotechnology and pharmaceutical services outsourcing growth
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Biotechnology and Pharmaceutical Services Outsourcing Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Forklift, by Service, 2019-2032 (USD Billion)
- 5.3. Product Design & Development
- 5.3.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Product Design & Development, by Region, 2019-2032 (USD Billion)
- 5.4. Consulting
- 5.4.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Consulting, by Region, 2019-2032 (USD Billion)
- 5.5. Regulatory Affairs
- 5.5.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Regulatory Affairs, by Region, 2019-2032 (USD Billion)
- 5.6. Product Maintenance
- 5.6.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Product Maintenance, by Region, 2019-2032 (USD Billion)
- 5.7. Auditing & Assessment
- 5.7.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Auditing & Assessment, by Region, 2019-2032 (USD Billion)
- 5.8. Product Testing & Validation
- 5.8.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Product Testing & Validation, by Region, 2019-2032 (USD Billion)
- 5.9. Others
- 5.9.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Others, by Region, 2019-2032 (USD Billion)
- 6. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 6.3. Biotech
- 6.3.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Biotech, by Region, 2019-2032 (USD Billion)
- 6.4. Pharma
- 6.4.1. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Pharma, by Region, 2019-2032 (USD Billion)
- 7. Global Biotechnology and Pharmaceutical Services Outsourcing Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Biotechnology and Pharmaceutical Services Outsourcing Market Assessment, By Geography, 2019-2032 (USD Billion)
- 7.3. Biotechnology and Pharmaceutical Services Outsourcing Market – North America
- 7.3.1. North America: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.3.2. North America: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.3.3. Biotechnology and Pharmaceutical Services Outsourcing Market – U.S.
- 7.3.3.1. U.S.: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.3.3.2. U.S.: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.3.4. Biotechnology and Pharmaceutical Services Outsourcing Market – Canada
- 7.3.4.1. Canada: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.3.4.2. Canada: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4. Biotechnology and Pharmaceutical Services Outsourcing Market – Europe
- 7.4.1. Europe: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.2. Europe: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4.3. Biotechnology and Pharmaceutical Services Outsourcing Market – UK
- 7.4.3.1. UK: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.3.2. UK: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4.4. Biotechnology and Pharmaceutical Services Outsourcing Market – France
- 7.4.4.1. France: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.4.2. France: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4.5. Biotechnology and Pharmaceutical Services Outsourcing Market – Germany
- 7.4.5.1. Germany: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.5.2. Germany: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4.6. Biotechnology and Pharmaceutical Services Outsourcing Market – Italy
- 7.4.6.1. Italy: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.6.2. Italy: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4.7. Biotechnology and Pharmaceutical Services Outsourcing Market – Spain
- 7.4.7.1. Spain: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.7.2. Spain: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4.8. Biotechnology and Pharmaceutical Services Outsourcing Market – Netherlands
- 7.4.8.1. Netherlands: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.8.2. Netherlands: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.4.9. Biotechnology and Pharmaceutical Services Outsourcing Market – Russia
- 7.4.9.1. Russia: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.4.9.2. Russia: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.5. Biotechnology and Pharmaceutical Services Outsourcing Market – Asia Pacific
- 7.5.1. Asia Pacific: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.5.3. Biotechnology and Pharmaceutical Services Outsourcing Market – China
- 7.5.3.1. China: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.5.3.2. China: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.5.4. Biotechnology and Pharmaceutical Services Outsourcing Market – India
- 7.5.4.1. India: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.5.4.2. India: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.5.5. Biotechnology and Pharmaceutical Services Outsourcing Market – Malaysia
- 7.5.5.1. Malaysia: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.5.5.2. Malaysia: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.5.6. Biotechnology and Pharmaceutical Services Outsourcing Market – Japan
- 7.5.6.1. Japan: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.5.6.2. Japan: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.5.7. Biotechnology and Pharmaceutical Services Outsourcing Market – Indonesia
- 7.5.7.1. Indonesia: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.5.7.2. Indonesia: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.5.8. Biotechnology and Pharmaceutical Services Outsourcing Market – South Korea
- 7.5.8.1. South Korea: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.5.8.2. South Korea: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.6. Biotechnology and Pharmaceutical Services Outsourcing Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.6.3. Biotechnology and Pharmaceutical Services Outsourcing Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.6.3.2. Saudi Arabia: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.6.4. Biotechnology and Pharmaceutical Services Outsourcing Market – UAE
- 7.6.4.1. UAE: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.6.4.2. UAE: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.6.5. Biotechnology and Pharmaceutical Services Outsourcing Market – Israel
- 7.6.5.1. Israel: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.6.5.2. Israel: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.6.6. Biotechnology and Pharmaceutical Services Outsourcing Market – South Africa
- 7.6.6.1. South Africa: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.6.6.2. South Africa: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.7. Biotechnology and Pharmaceutical Services Outsourcing Market – Latin America
- 7.7.1. Latin America: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.7.3. Biotechnology and Pharmaceutical Services Outsourcing Market – Mexico
- 7.7.3.1. Mexico: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.7.3.2. Mexico: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.7.4. Biotechnology and Pharmaceutical Services Outsourcing Market – Brazil
- 7.7.4.1. Brazil: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.7.4.2. Brazil: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 7.7.5. Biotechnology and Pharmaceutical Services Outsourcing Market – Argentina
- 7.7.5.1. Argentina: Biotechnology and Pharmaceutical Services Outsourcing Market, by End-User, 2019-2032 (USD Billion)
- 7.7.5.2. Argentina: Biotechnology and Pharmaceutical Services Outsourcing Market, by Service, 2019-2032 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Charles River Laboratories International, Inc
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. ICON plc
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. IQVIA Holdings Inc
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Laboratory Corporation of America Holdings (LabCorp)
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Lonza Group
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Parexel International Corporation
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Pharmaceutical Product Development, LLC (PPD)
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Sartorius Stedim Biotech
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Syneos Health
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Thermo Fisher Scientific Inc
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. WuXi AppTec
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Vetter Pharma International GmbH
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.